Omar M. Ibrahim

Benchmarking antimicrobial drug use in hospitals

R. Polk, Omar M. Ibrahim, 2012, Expert review of anti-infective therapy.

Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges.

R. Polk, Omar M. Ibrahim, Omar M Ibrahim, 2014, Infectious disease clinics of North America.

DEVELOPMENT AND COMPARISON OF RISK-ADJUSTED MODELS TO BENCHMARK ANTIBIOTIC USE IN THE UNIVERSITY HEALTHSYSTEM CONSORTIUM HOSPITALS

Omar M. Ibrahim, 2012 .

Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers

A. Pakyz, R. Polk, Omar M. Ibrahim, 2009, Infection Control & Hospital Epidemiology.

Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does β-Lactam Class Matter?

Omar M. Ibrahim, R. Mercier, D. Jacobs, 2019, Antimicrobial Agents and Chemotherapy.

Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals.

S. Hohmann, R. Polk, Omar M. Ibrahim, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

C. Walraven, P. Hall, Omar M. Ibrahim, 2013, Antimicrobial Agents and Chemotherapy.

Impact of an Intravenous Trimethoprim/Sulfamethoxazole Shortage on Treatment Outcomes Among HIV-Infected Patients with Pneumocystis jirovecii Pneumonia

Omar M. Ibrahim, R. Mercier, T. Dilworth, 2014, Journal of managed care & specialty pharmacy.